"Peanuts" for big pharma will still be many multiples of current Market Cap. Let's chat about it in December, or, before.
Also, tht's why I chose the PABOA's, that 4 extra months was more expensive that the Os, but, much less risky. $ months extra LIFE!! A punter's best wish.
In saying that, my dabble in the Options is nowhere near my holding in the actual shares.
Ann: Updated guidance for PAT-DX1 phase 1 clinical study, page-42
-
- There are more pages in this discussion • 84 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 3823088 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 2310786 | 5 |
View Market Depth
| Last trade - 10.06am 18/09/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable